These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32936384)

  • 1. DNA methylation in the upstream CpG island of the GPER locus and its relationship with GPER expression in colon cancer cell lines.
    Pal U; Ghosh S; Limaye AM
    Mol Biol Rep; 2020 Oct; 47(10):7547-7555. PubMed ID: 32936384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
    Manjegowda MC; Gupta PS; Limaye AM
    Gene; 2017 May; 614():65-73. PubMed ID: 28286086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPER Promoter Methylation Controls GPER Expression in Breast Cancer Patients.
    Weissenborn C; Ignatov T; Nass N; Kalinski T; Dan Costa S; Zenclussen AC; Ignatov A
    Cancer Invest; 2017 Feb; 35(2):100-107. PubMed ID: 28118074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
    Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
    Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
    Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of promoter methylation and altered expression of hMLH1 in gastric cancer cell lines with microsatellite instability.
    Kang YH; Bae SI; Kim WH
    J Cancer Res Clin Oncol; 2002 Mar; 128(3):119-24. PubMed ID: 11935297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma.
    Petak I; Danam RP; Tillman DM; Vernes R; Howell SR; Berczi L; Kopper L; Brent TP; Houghton JA
    Cell Death Differ; 2003 Feb; 10(2):211-7. PubMed ID: 12700649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
    Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
    Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.
    Toyota M; Shen L; Ohe-Toyota M; Hamilton SR; Sinicrope FA; Issa JP
    Cancer Res; 2000 Aug; 60(15):4044-8. PubMed ID: 10945606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
    Zekas E; Prossnitz ER
    BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide profiling of DNA methylation in human cancer cells.
    Ogoshi K; Hashimoto S; Nakatani Y; Qu W; Oshima K; Tokunaga K; Sugano S; Hattori M; Morishita S; Matsushima K
    Genomics; 2011 Oct; 98(4):280-7. PubMed ID: 21821115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro.
    Han N; Heublein S; Jeschke U; Kuhn C; Hester A; Czogalla B; Mahner S; Rottmann M; Mayr D; Schmoeckel E; Trillsch F
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived.
    Ueki T; Walter KM; Skinner H; Jaffee E; Hruban RH; Goggins M
    Oncogene; 2002 Mar; 21(13):2114-7. PubMed ID: 11960385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer.
    Tian S; Zhan N; Li R; Dong W
    Med Sci Monit; 2019 Apr; 25():3115-3126. PubMed ID: 31028714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of DNA methylation in 3' genomic regions that are associated with upregulation of gene expression in colorectal cancer.
    Smith JF; Mahmood S; Song F; Morrow A; Smiraglia D; Zhang X; Rajput A; Higgins MJ; Krumm A; Petrelli NJ; Costello JF; Nagase H; Plass C; Held WA
    Epigenetics; 2007 Sep; 2(3):161-72. PubMed ID: 17965620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of CpG loci in 5'-flanking region alters steady-state expression of adenomatous polyposis coli gene in colon cancer cell lines.
    Sakamoto Y; Kitazawa R; Maeda S; Kitazawa S
    J Cell Biochem; 2001; 80(3):415-23. PubMed ID: 11135372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of methylated CpG sites of hMLH1 promoter in primary gastric carcinoma with microsatellite instability.
    Kang GH; Lee S; Shim YH; Kim JC; Ro JY
    Pathol Int; 2002 Dec; 52(12):764-8. PubMed ID: 12588445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
    Vaidya H; Rumph C; Katula KS
    PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.